Thermo Fisher Scientific Stock price

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
580 USD -0.70% Intraday chart for Thermo Fisher Scientific -3.23% +9.28%
Sales 2024 * 43.01B Sales 2025 * 46.08B Capitalization 221B
Net income 2024 * 6.37B Net income 2025 * 6.94B EV / Sales 2024 * 5.66 x
Net Debt 2024 * 22.27B Net Debt 2025 * 17.46B EV / Sales 2025 * 5.18 x
P/E ratio 2024 *
35.2 x
P/E ratio 2025 *
31.2 x
Employees 122,000
Yield 2024 *
0.26%
Yield 2025 *
0.28%
Free-Float 87.09%
More Fundamentals * Assessed data
Dynamic Chart
Thermo Fisher Scientific Insider Sold Shares Worth $5,945,759, According to a Recent SEC Filing MT
Thermo Fisher Scientific Insider Sold Shares Worth $11,933,356, According to a Recent SEC Filing MT
Thermo Fisher Scientific Insider Sold Shares Worth $8,591,221, According to a Recent SEC Filing MT
Thermo Fisher Scientific Inc. Launches Corevitas Clinical Registry in Generalized Pustular Psoriasis CI
Transcript : Thermo Fisher Scientific Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-06-2024 09:10 AM
Thermo Fisher Scientific Insider Sold Shares Worth $5,710,818, According to a Recent SEC Filing MT
Thermo Fisher Scientific Extends Tender Offer Expiration for Olink Holding Shares MT
Thermo Fisher Scientific Insider Sold Shares Worth $11,348,955, According to a Recent SEC Filing MT
Agilent reports better-than-expected first quarter results, shares rise RE
LBT Innovations Delivers APAS Hardware, Software to Thermo Fisher MT
Thermo Fisher Scientific Raises Quarterly Dividend 11% to 39 Cents Per Share DJ
Thermo Fisher Scientific Increases Quarterly Dividend 11% to $0.39 Per Share, Payable April 15 to Shareholders of Record March 15 MT
Thermo Fisher Scientific Inc. Increases Quarterly Cash Dividend, Payable on April 15, 2024 CI
Thermo Fisher Scientific Inc. Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs CI
IQVIA quarterly results beat estimates on strong demand for research services RE
More news
1 day-0.70%
1 week-2.94%
Current month+1.73%
1 month+5.88%
3 months+11.97%
6 months+12.52%
Current year+9.28%
More quotes
1 week
573.73
Extreme 573.73
600.62
1 month
542.35
Extreme 542.35
603.82
Current year
527.32
Extreme 527.32
603.82
1 year
415.60
Extreme 415.6
603.82
3 years
415.60
Extreme 415.6
672.34
5 years
250.21
Extreme 250.21
672.34
10 years
107.33
Extreme 107.33
672.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 55 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Date Price Change Volume
24-03-18 580 -0.70% 1,554,421
24-03-15 584.2 -0.13% 1,920,147
24-03-14 584.9 -1.42% 1,757,994
24-03-13 593.3 -0.66% 1,035,189
24-03-12 597.2 -0.36% 1,146,315

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
580 USD
Average target price
598.9 USD
Spread / Average Target
+3.26%
Consensus
  1. Stock
  2. Equities
  3. Stock Thermo Fisher Scientific - Nyse